商业保险高风险流感患儿抗病毒药物使用相关因素分析
哮喘、西部和南部地区、紧急护理机构及特定保险计划与抗病毒药物使用增加相关,而低龄、急诊科、中西部和东北部地区及特定保险计划与使用减少相关。尽管指南推荐所有高风险患儿使用抗病毒药物,仍有近半数未接受治疗。
要点
- 高风险流感患儿中仅54.1%在诊断后2天内获得抗病毒药物。
- 哮喘、西部/南部地区、紧急护理机构与抗病毒药物使用增加相关。
- 低龄、急诊科、中西部/东北部地区与抗病毒药物使用减少相关。
核心结论
- 尽管国家指南推荐所有高风险流感并发症患儿接受抗病毒治疗,本研究中近半数高风险患儿未获得抗病毒药物。
- 多种临床和医疗系统因素与抗病毒药物发放减少相关,可用于指导未来改善脆弱流感患儿治疗的干预措施。
研究设计与样本
- 回顾性队列研究,使用Merative MarketScan商业索赔与 encounters 数据库,纳入2016-2020流感季年龄<18岁的门诊就诊个体。
- 高风险状态依据美国感染病学会定义,包括年龄、特定合并症、妊娠或产后状态及长期护理机构居住。
- 主要结局为流感诊断后2天内发放抗病毒药物(奥司他韦、扎那米韦、巴洛沙韦)。
- 采用改良泊松回归确定与抗病毒药物发放相关的临床因素。
主要发现
- 与抗病毒药物使用增加相关的因素包括哮喘、美国西部和南部地理区域、紧急护理机构及特定健康保险计划。
- 与抗病毒药物使用减少相关的因素包括较低年龄、急诊科机构、中西部和东北部地理区域及健康保险计划。
关键数值与推荐
- 高风险状态定义依据美国感染病学会定义,包括年龄、特定合并症、妊娠或产后状态及长期护理机构居住。
- 主要结局为流感诊断后2天内发放抗病毒药物(奥司他韦、扎那米韦、巴洛沙韦)。
临床怎么用
- 临床医生应认识到近半数高风险流感患儿未接受指南推荐的抗病毒治疗,需关注低龄、急诊科就诊及特定地区等高危因素。
- 针对抗病毒药物使用减少的相关因素,可设计干预措施以提高高风险流感患儿的抗病毒治疗率。
局限性
- 本研究为回顾性队列研究,使用商业索赔数据库,可能受编码不完整或误分类影响。
- 研究仅纳入商业保险人群,结果可能不适用于无保险或其他保险类型的儿童。
- 未报告抗病毒药物发放与临床结局(如并发症或住院)的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the prevalence of antiviral drug use in children in the US with influenza at high risk for complications and to identify factors associated with dispensing. STUDY DESIGN: We conducted a retrospective cohort study of outpatient visits for individuals < 18 years during the 2016-2020 influenza seasons using the Merative MarketScan Commercial Claims and Encounter database. High-risk status was defined using Infectious Disease Society of America definitions and included: age, specific comorbidities, pregnancy or postpartum status, and living in a long-term care facility. The primary outcome was antiviral (oseltamivir, zanamivir, baloxavir) dispensing within 2 days of influenza diagnosis. We determined clinical factors associated with antiviral dispensing using modified Poisson regression. RESULTS: A total of 372 372 influenza episodes were identified among 331 389 children at high risk for influenza complications and included in this study. The median (IQR) age was 4.0 years (2.0, 9.0). Overall, during 201 638 (54.1%) episodes of the influenza, antiviral treatment was dispensed. Factors associated with increased antiviral use included asthma, West and South US geographic regions, urgent care settings, and specific health insurance plans. Factors associated with decreased antiviral use include younger age, emergency department setting, Midwest and Northeast geographic regions, and health insurance plans. CONCLUSION: Despite national guidelines recommending that all children at high risk for influenza complications receive antiviral treatment, nearly half of these children at high-risk did not receive an antiviral in our study. We identify several factors associated with decreased antiviral treatment that may serve to inform future interventions aiming to improve the care of vulnerable children with influenza.
引用
- Abdelaziz A, Sarker J, Lien PW, et al. Factors Associated with Antiviral Drug Use Among Commercially Insured Children at High Risk for Complications of Influenza. J Pediatr. 2025. PMID: 40185310. doi:10.1016/j.jpeds.2025.114574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。